This book covers the principles, practice, and potential of pharmacogenomics and personalized medicine, employing patient case profiles to illustrate key concepts and clinical applications. Featuring contributions from well-established pharmacologists/scientists, this authoritative text depicts the use of genetic biomarkers in drug discovery and development, laboratory medicine, and clinical services. It describes the practice of pharmacogenomics in the treatment of cancers, cardiovascular diseases, neurologic and psychiatric disorders, and pulmonary diseases. It also discusses the merging of pharmacogenomics and alternative medicine, and the integration of pharmacogenomics into pharmacoeconomics.